Cannabix Technologies Evaluating Expansion into Breath-Based Health and Biomarker Market with Proprietary BCU “VOC” Platform
Financial Post ·
VANCOUVER, British Columbia, Oct. 28, 2026 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”), a developer of marijuana and alcohol breath testing technologies, announces that it is evaluating its Breath Collection Unit (BCU) technology, for strategic expansion into the rapidly advancing breath biomarker research and diagnostics sector. […]
We seek Safe Harbor. On behalf of the Board of Directors Read More